The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective study of unresectable stage III or stage IV melanoma refractory to immune checkpoint and BRAF/MEK inhibitors, treated with triplet vs doublet therapy: A single institution experience.
 
Hariharasudan Mani
No Relationships to Disclose
 
Nicole Nester
No Relationships to Disclose
 
Grace Rauscher
No Relationships to Disclose
 
Timothy Johnson
No Relationships to Disclose
 
Zeeshan Hafeez
No Relationships to Disclose
 
Darshan Lal
No Relationships to Disclose
 
Colby Presley
No Relationships to Disclose
 
Hope Kincaid
No Relationships to Disclose
 
Alyson McIntosh
No Relationships to Disclose
 
Aaron Blackham
No Relationships to Disclose
 
Suresh Nair
Research Funding - Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Nektar (Inst); Strata Oncology (Inst)